Determination of Duration of the Intensive Phase of Chemotherapy for Respiratory Tuberculosis in Children without Bacterial Excretion and at No Risk of Multiple and Extensive Drug Resistance

The objective of the study: to develop criteria to evaluate the duration of the intensive phase of chemotherapy for respiratory tuberculosis in children without bacterial excretion and at no risk of multiple and extensive drug resistance of tuberculous mycobacteria.

Subjects and methods. Totally, 93 patients with newly diagnosed respiratory tuberculosis without bacterial excretion and at no risk of multiple and extensive drug resistance of tuberculous mycobacteria. Their age varied from 2 to 12 years old. Regimen III was used: the intensive phase – 4 drugs (isoniazid, rifampicin, pyrazinamide, ethambutol – HRZE).

Results. The intensive phase lasted for 2 months in 39.8% of cases – the main criteria were achieved (relief of intoxication symptoms, normal blood rates, positive or stable CT changes) after 2 months and there was no indication to extend the duration of it. The intensive phase lasted for 3 months in 37.6% of cases – the main criteria were achieved after 2 months and there was at least one additional indication to extend it (17.2%); and the main criteria were achieved after 3 months and there was no indication to extend the duration of it (20.4%). The intensive phase lasted for more than 3 months (4 to 6 months) in 22.6% of cases – the main criteria were achieved after 3 months and there was at least one additional indication to extend it (12.9%), as well as in the case of failure to achieve the main criteria after 3 months regardless of the presence/absence of additional indications to extend its duration (9.7%).

Conclusion. Various combinations of the main criteria and additional indications made the basis for differential approach to determining the duration of the intensive phase of chemotherapy in children with respiratory tuberculosis 

1. Аksenova V.А., Sterlikov S.А., Belilovsky E.M., Kazykina T.N., Rusakova L.I. Tuberculosis epidemiology in children. Sovremennye Problemy Zdravookhraneniya i Meditsinskoy Statistiki, 2019, no. 1, pp. 8-43. (In Russ.) doi: 10.24411/2312-2935-2019-10002.

2. Dovgalyuk I.F., Nergacheva V.V., Zakhovaeva O.P., Verbinskaya V.V. Management tactics for children with lesion of chest lymph nodes in the phase of calcification. Probl. Tub., 2001, no. 1, pp. 20-22. (In Russ.)

3. Ershova N.G. Effektivnost lecheniya vpervye vyyavlennogo tuberkuleza organov dykhaniya u detey starshego vozrasta i podrostkov. Avteref. diss. kand. med. nauk. [The effectiveness of treatment for newly diagnosed respiratory tuberculosis in senior children and adolescents. Syn. Cand. Diss.]. Moscow, 2009, 25 p.

4. Mitinskaya L.А., Elufimova V.F., Yukhimenko N.V., Chernousova L.N., Аbdullaev R.Yu. Diagnosis of latent activity of primary respiratory tuberculosis in the calcification phase in children. Probl. Tub., 2004, no. 1, pp. 16-20. (In Russ.)

5. Nechaeva O.B. Tuberculosis in children in Russia. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 11, pp. 12-20. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-11-12-20.

6. Ovchinnikova Yu.E., Dovgalyuk I.F. Use of individual chemotherapy regimes in tuberculosis of chest lymph nodes in children. Tuberculosis and Lung Diseases, 2011, vol. 88, no. 3, pp. 34-38. (In Russ.)

7. Porkulevich N.I., Mordyk А.V., Tsygankova E.А. The changes in the structure of localizations, prevalence and clinical forms of tuberculosis in children from 1985 to 2015 in Omsk Region. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 9, pp. 55-59. (In Russ.)

8. Edict no. 951 by RF Ministry as of 29.12.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. (In Russ.) Moscow, 2014, 42 p.

9. Smailova G.А., Sagintaeva G.L., Shaymuratov Sh.Sh. Reasons for extending the intensive phase of chemotherapy in newly diagnosed pulmonary tuberculosis patients. Materialele Conferinţei Internaţionale INSPIR Iaşi-Chişinău, 14-16 octombrie, 2011. Buletinul Academiei De Stiinţe A Moldovei Stiinţe Medicale, 2011, no. 4 (32), pp. 43-44.

10. Strukov А.I., Solovieva I.P. Morfologiya tuberkulyoza v sovremennykh usloviyakh. [Tuberculosis morphology in the current situation]. Moscow, Meditsina Publ., 1986, 232 p.

11. Tuberkulez u detey. [Tuberculosis in children]. V.A. Aksenova, eds., Moscow, GEOTAR-Media Publ., 2007, 272 p.

12. Tuberkulez u detey. Klinicheskie rekomendatsii. [Tuberculosis in children. Guidelines]. ROF Publ., 2020, 54 p. Epub., Available: http://cr.rosminzdrav.ru/schema/507_1 (Accessed 09.04.2021).

13. Federalnye klinicheskiye rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya s mnozhestvennoy i shirokoy lekarstennoy ustoichivostyu vozbuditelya. [Federal clinical guidelines for diagnosis and treatment of respiratory tuberculosis with multiple and extensive drug resistance]. Moscow, Tver, OOO Izdatelstvo Triada Publ., 2014, 72 p.

14. Tsygankova E.А., Mordyk А.V. Specific age-related clinical manifestations of pediatric tuberculosis. Omskiy Nauchny Vestnik, 2012, no. 1 (108), pp. 72-75. (In Russ.)

15. Shtefko V.G. Patologicheskaya anatomiya pervichnoy tuberkuleznoy infektsii v detskom vozraste. [Pathological anatomy of primary tuberculous infection in childhood]. Leningrad, Medgiz Publ., 1938, 266 p.

16. Shtefko V.G. Patologicheskaya anatomiya tuberkuleza legkikh. [Pathological anatomy of pulmonary tuberculosis]. Moscow, Gos. Med. Izd-vo., 1933, 72 p.

17. Shulgina M.V., Narvskaya O.V., Mokrousov I.V., Vasilyeva I.А. Patogennye i uslovno-patogennye mikobakterii. [Pathogenic and opportunistic pathogenic mycobacteria]. Moscow, New Terra Publ., 2018, 104 p.